Lv21
110 积分 2025-07-17 加入
Developing and validating a prediction tool for identifying significant liver fibrosis in children with chronic hepatitis B: An interpretable machine learning model
9小时前
已完结
Machine learning models to further identify advantaged populations that can achieve functional cure of chronic hepatitis B virus infection after receiving Peg-IFN alpha treatment
7天前
已完结
Interpretable machine learning model for prediction functional cure in chronic hepatitis B patients receiving Peg-IFN therapy: A multi-center study
15天前
已完结
Prevention of Liver Fibrosis and Hepatocellular Carcinoma Using Antiplatelet Drugs
1个月前
已完结
Shared mechanistic pathways of glucagon signalling: Unlocking its potential for treating obesity, metabolic dysfunction‐associated steatotic liver disease, and other cardio‐kidney‐metabolic conditions
2个月前
已完结
Multiparametric MRI Evaluation of Liver Fat and Iron after Glucagon-like Peptide-1 Receptor and Glucagon Receptor Dual-Agonist Treatment in a High-Fat Diet–induced Mouse Model
2个月前
已完结
Treatment for liver cancer: From sorafenib to natural products
2个月前
已完结
Adherence and forgiveness of two modern ART regimens: lamivudine/dolutegravir and emtricitabine/tenofovir alafenamide/rilpivirine
3个月前
已关闭
ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B
5个月前
已完结
皖公网安备34019202002308
